CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+1.24%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.46B
AUM Growth
+$2.46B
(-4%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
47.28%
Holding
111
New
8
Increased
8
Reduced
35
Closed
20
Top Buys
| 1 |
Erasca
ERAS
|
$217M |
| 2 |
Immuneering
IMRX
|
$58.5M |
| 3 |
Tango Therapeutics
TNGX
|
$38.8M |
| 4 |
Cytokinetics
CYTK
|
$35.7M |
| 5 |
Tyra Biosciences
TYRA
|
$18.2M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$52M |
| 2 |
Twist Bioscience
TWST
|
$24.7M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$22M |
| 4 |
908 Devices
MASS
|
$21.1M |
| 5 |
C4 Therapeutics
CCCC
|
$13.4M |
Sector Composition
| 1 | Healthcare | 99.61% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$358M
| $29M | 1.18% |
968,550
| – | – |
|
|
CNTA
27
Centessa Pharmaceuticals
CNTA
$2.13B
| $28.7M | 1.17% |
1,727,273
+300,000
| +21% | +$4.99M |
|
28
Zymeworks
ZYME
$1.07B
| $27.6M | 1.12% |
950,000
-371,936
| -28% | -$10.8M |
|
29
Ascendis Pharma
ASND
$12.1B
| $27.1M | 1.1% |
170,000
+95,000
| +127% | +$15.1M |
|
30
Aclaris Therapeutics
ACRS
$223M
| $27M | 1.1% |
1,500,000
-500,000
| -25% | -$9M |
|
|
AGEN
31
Agenus
AGEN
$136M
| $25.2M | 1.03% |
4,807,557
| – | – |
|
|
IGMS
32
DELISTED
IGM Biosciences
IGMS
| $23M | 0.94% |
350,000
+100,000
| +40% | +$6.58M |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.2M | 0.86% |
120,000
-55,000
| -31% | -$9.73M |
|
|
AXNX
34
DELISTED
Axonics, Inc. Common Stock
AXNX
| $21M | 0.85% |
322,240
| – | – |
|
|
LBPH
35
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $20.2M | 0.82% |
2,273,221
-48,182
| -2% | -$427K |
|
36
Cabaletta Bio
CABA
$144M
| $19.6M | 0.8% |
1,611,623
| – | – |
|
37
Praxis Precision Medicines
PRAX
$980M
| $18.9M | 0.77% |
1,024,161
+16
| +0% | +$277 |
|
|
38
Tyra Biosciences
TYRA
$657M
| $18.2M | 0.74% |
+1,069,932
| New | +$18.2M |
|
|
VECT
39
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $17.2M | 0.7% |
2,226,128
| – | – |
|
40
Tourmaline Bio
TRML
$645M
| $16.3M | 0.66% |
1,215,847
| – | – |
|
|
BPMC
41
DELISTED
Blueprint Medicines
BPMC
| $15.4M | 0.63% |
150,000
-87,546
| -37% | -$9M |
|
|
ELEV
42
DELISTED
Elevation Oncology
ELEV
| $15.1M | 0.62% |
1,983,165
| – | – |
|
|
IMAB
43
I-MAB
IMAB
$380M
| $14.5M | 0.59% |
+200,000
| New | +$14.5M |
|
44
Y-mAbs Therapeutics
YMAB
$390M
| $14.3M | 0.58% |
500,000
-300,000
| -38% | -$8.56M |
|
45
Akero Therapeutics
AKRO
$3.65B
| $13.4M | 0.54% |
600,000
| – | – |
|
46
GH Research
GHRS
$870M
| $13.1M | 0.53% |
608,123
| – | – |
|
47
Omeros
OMER
$284M
| $13.1M | 0.53% |
950,000
-250,000
| -21% | -$3.45M |
|
|
ICVX
48
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $12.2M | 0.5% |
+426,393
| New | +$12.2M |
|
49
Pharvaris
PHVS
$1.41B
| $12.2M | 0.5% |
689,731
-55,132
| -7% | -$977K |
|
|
CNTB
50
Connect Biopharma
CNTB
$111M
| $12M | 0.49% |
500,000
-150,000
| -23% | -$3.59M |
|